- Draft Order on Drug Prices Proposes Easing Regulations New York Times by Sheila Kaplan and Katie Thomas—In the early days of his administration, President Trump did not hesitate to bash the drug industry. But a draft of an executive order on drug prices appears to give the pharmaceutical industry much of what it has asked for—and no guarantee that costs to consumers will drop. The draft, which The New York Times obtained on Tuesday, is light on specifics but clear on philosophy: Easing regulatory hurdles for the drug industry is the best way to get prices down. "I do believe that the president wants to do something to lower drug prices for people, but this is a far cry from what he said on the campaign trail," said David Mitchell, the founder of Patients for Affordable Drugs, a nonprofit that does not take money from the industry.